Literature DB >> 31881269

Addressing the epidemic of antibiotic "allergy" over-diagnosis.

Eric Macy1.   

Abstract

OBJECTIVE: An epidemic of antibiotic allergy is occurring. DATA SOURCES: Articles published since 2008. STUDY SELECTIONS: Articles on antibiotic allergy and stewardship.
RESULTS: A number of overlapping factors contribute. The most important factor is antibiotic overuse. Antibiotics are commonly used in situations in which no antibiotics are indicated. Thirty percent to 50% of ambulatory antibiotic use may be inappropriate. The duration of indicated antibiotic use is often excessive, which leads to more side effects. All antibiotic use can result in adverse reactions, and a fraction of these will be dutifully recorded as an allergy in the electronic health record (EHR). Most EHRs are not well structured to accurately convey information on expected side effects that have occurred, metabolic or other contraindications, dose-related or situational toxicities, personal preferences, clinically significant immunologically mediated hypersensitivity, and other reasons a particular patient may not want or should not be given a specific drug or type of drug in the future. As populations age, their accumulated baggage of reported antibiotic allergies increase. Suspected antibiotic allergy is rarely confirmed with appropriate testing or rechallenge. Patients then receive suboptimal antibiotic therapy and experience more side effects, treatment failures, and serious antibiotic-resistant infections. Reporting an antibiotic allergy in the EHR is nominally done to improve patient safety, but unfortunately, this is often not the actual result.
CONCLUSION: Audit and feedback, to help ensure adherence to Choosing Wisely recommendations and good antibiotic stewardship practices, can help reduce inappropriate antibiotic use. Restructuring EHRs to facilitate correct drug intolerance reporting, along with active antibiotic allergy delabeling programs, can help stem this epidemic.
Copyright © 2019 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31881269     DOI: 10.1016/j.anai.2019.12.016

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  5 in total

Review 1.  Practical Management of New-Onset Urticaria and Angioedema Presenting in Primary Care, Urgent Care, and the Emergency Department.

Authors:  Eric Macy
Journal:  Perm J       Date:  2021-11-22

2.  Drug allergy labeling and delabeling in the coronavirus disease 2019 era: What is important and what do we need to know.

Authors:  Mariana C Castells
Journal:  Ann Allergy Asthma Immunol       Date:  2020-06       Impact factor: 6.347

3.  Prevalence and Impact of Reported Drug Allergies among Rheumatology Patients.

Authors:  Shirley Chiu Wai Chan; Winnie Wan Yin Yeung; Jane Chi Yan Wong; Ernest Sing Hong Chui; Matthew Shing Him Lee; Ho Yin Chung; Tommy Tsang Cheung; Chak Sing Lau; Philip Hei Li
Journal:  Diagnostics (Basel)       Date:  2020-11-09

4.  Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.

Authors:  Eric Macy; Shalin Pandya; Javed Sheikh; Amber Burnette; Jiaxiao M Shi; Joanie Chung; Nancy Gin; William Crawford; Jing Zhang
Journal:  J Allergy Clin Immunol Pract       Date:  2021-12-29

5.  Anaphylactic shock following the diagnosis of coronavirus disease 2019.

Authors:  Alberto Alvarez-Perea; María Luisa Baeza
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-01       Impact factor: 6.347

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.